Evidence map›Paper›PMID 35844460›Full record

ArticleComputational and mathematical methods in medicine2022

Survival Prediction Model for Patients with Esophageal Squamous Cell Carcinoma Based on the Parameter-Optimized Deep Belief Network Using the Improved Archimedes Optimization Algorithm.

Yanfeng Wang, Wenhao Zhang, Junwei Sun, Lidong Wang, Xin Song, Xueke Zhao

Abstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanfeng WangSchool of Electrical and Information Engineering, Zhengzhou University of Light Industry, Zhengzhou 450000, China.
Wenhao ZhangSchool of Electrical and Information Engineering, Zhengzhou University of Light Industry, Zhengzhou 450000, China.ORCID https://orcid.org/0000-0003-3917-5599
Junwei SunSchool of Electrical and Information Engineering, Zhengzhou University of Light Industry, Zhengzhou 450000, China.ORCID https://orcid.org/0000-0001-8518-5064
Lidong WangState Key Laboratory of Esophageal Cancer Prevention & Treatment and Henan Key Laboratory for Esophageal Cancer Research of the First Affiliated Hospital, Zhengzhou University, Zhengzhou 450066, China.
Xin SongState Key Laboratory of Esophageal Cancer Prevention & Treatment and Henan Key Laboratory for Esophageal Cancer Research of the First Affiliated Hospital, Zhengzhou University, Zhengzhou 450066, China.
Xueke ZhaoState Key Laboratory of Esophageal Cancer Prevention & Treatment and Henan Key Laboratory for Esophageal Cancer Research of the First Affiliated Hospital, Zhengzhou University, Zhengzhou 450066, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the highest incidence and mortality cancers in the world. An effective survival prediction model can improve the quality of patients' survival. Therefore, a parameter-optimized deep belief network based on the improved Archimedes optimization algorithm is proposed in this paper for the survival prediction of patients with ESCC. Firstly, a combination of features significantly associated with the survival of patients is found by the minimum redundancy and maximum relevancy (MRMR) algorithm. Secondly, a DBN network is introduced to make predictions for survival of patients. Aiming at the problem that the deep belief network model is affected by parameters in the construction process, this paper uses the Archimedes optimization algorithm to optimize the learning rate

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaAlgorithmsHumans

Identifiers

PMID35844460
PMCPMC9286952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.